Newsroom

The latest news and stats on sleep apnea and respiratory care from
ResMed, the world's leading tech-driven medical device company. 

Meet AirFit N30i: ResMed adds top-of-head option to its CPAP mask family

Read the press release

Meet AirFit N30i: ResMed adds top-of-head option to its CPAP mask family

Read the press release

Latest news

Latest news

January 21, 2019

SAN DIEGO, January 21, 2019 – ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal...

January 8, 2019

SAN DIEGO, January 8, 2019 – ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen...

January 7, 2019

SAN DIEGO, January 7, 2019 – ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has...

See all news releases

Fast facts - Landing Page

Fast facts

  • +1.5 MILLION
    people use myAir to self monitor their CPAP treatment
  • +6 MILLION
    people remotely monitored on cloud connected CPAP machines and ventilators every night
  • +14 MILLION
    lives changed by a ResMed device, mask or accessory

See all fast facts

In the news

In the news

October 29, 2018
Med Device Online
October 15, 2018
Health Europa

See all articles

Infographics - Landing Page

Infographics

Learn about respiratory conditions, their effects on our health and communities,
and how ResMed helps millions live and breathe better.

 

See all infographics

Media resources - Gray, Left - Landing Page

Media resources

Find everything you need.
Ask us for more information.

See all resources

Media contacts - Gray, Right - Landing Page

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Email Alerts - Landing Page

Sign up to receive ResMed news releases when they publish.

Subscribe

 

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages